{"id":"W4282916823","doi":"10.1016/j.esmoop.2022.100510","title":"Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer","year":2022,"lang":"en","type":"review","venue":"ESMO Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Sanofi Genzyme; Genentech; Takeda Pharmaceutical Company; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Merck; Bayer; Astellas Pharma Global Development; AstraZeneca; Amgen; Pfizer; Astellas Pharma; Daiichi Sankyo Company; Clovis Oncology; Astellas Pharma US","keywords":"Enzalutamide; Prostate cancer; Hazard ratio; Medicine; Placebo; Cabazitaxel; Oncology; Internal medicine; Antiandrogen; Confidence interval; Androgen deprivation therapy; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01922541,0.001464411,0.002727574,0.0009377451,0.0002715051,0.0008545651,0.001198383,0.001090846,0.01024424],"category_scores_gemma":[0.03160702,0.0003729736,0.006447959,0.0008278725,0.000873781,0.0006868964,0.001352746,0.001761626,0.0003919721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001201229,"about_ca_system_score_gemma":0.001219762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001961036,"about_ca_topic_score_gemma":0.001664426,"domain_scores_codex":[0.9776093,0.01818985,0.001135403,0.001290131,0.001371149,0.0004042333],"domain_scores_gemma":[0.9897652,0.006347249,0.001971506,0.001132835,0.0005404817,0.0002428242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7563306,0.002125524,0.01148404,0.006859659,0.06872336,0.0001021225,0.0002838798,0.02247799,0.003720954,0.007402997,0.002297963,0.118191],"study_design_scores_gemma":[0.3907147,0.195226,0.1030364,0.001593345,0.151945,0.0004884714,0.0003403069,0.08965901,0.01868975,0.02859583,0.0192195,0.0004915509],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8907667,0.01366619,0.06039086,0.000728506,0.001522815,0.01464306,0.006672329,0.0004634376,0.01114621],"genre_scores_gemma":[0.969535,0.0008153194,0.0219158,0.0002812458,0.00008552411,0.004340264,0.001375397,0.00003199962,0.001619453],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01922541,"threshold_uncertainty_score":0.101675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.270638878063148,"score_gpt":0.4758512421177813,"score_spread":0.2052123640546333,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}